Literature DB >> 9827936

Successful adoptive immunotherapy for relapse of AML 9 years after T-cell-depleted BMT.

H Bertz1, R Kunzman, D Bunjes, J Finke.   

Abstract

Relapse is one of the main problems which can occur following allogeneic transplantation for haematological malignancies. In this situation the enhancement of the graft-versus-leukaemia effect by transfusion of donor buffy coats with or without cytokines may lead to complete remission especially in myeloid leukaemias. FISH (fluorescence in situ hybridization) is a sensitive method to monitor chimaerism in gender-different transplantation. We report a case of successful buffy coat transfer therapy > 9 years after bone marrow transplantation. This is the longest interval reported, to our knowledge, between transplantation to relapse, which was treated by adoptive immunotherapy. Complete donor chimaerism was confirmed by FISH.

Entities:  

Mesh:

Year:  1998        PMID: 9827936     DOI: 10.1046/j.1365-2141.1998.01007.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  1 in total

1.  Late relapse of acute myelogenous leukemia followed by epstein-barr virus-associated lymphoproliferative disease 11 years after allogeneic bone marrow transplantation.

Authors:  Yoshikane Kikushige; Ken Takase; Toshihiro Miyamoto; Akihiko Numata; Kenjiro Kamesaki; Takahiro Fukuda; Koji Nagafuji; Hisashi Gondo; Mine Harada
Journal:  Int J Hematol       Date:  2006-12       Impact factor: 2.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.